Last edition
News about Global Pharma
Aurobindo Pharma Gets USFDA Nod for HIV Drug
Aurobindo Pharma has received approval from the US health regulator to market a generic medication for the treatment of human immunodeficiency virus (HIV-1) infection.
Global Pharma | 02/12/2023 | By Manvi | 767
Cryoport Inc. and Nippon Express announced a strategic partnership to provide temperature-controlled supply chain services for the life sciences industry on a global basis.
Global Pharma | 29/11/2023 | By Manvi | 642
Lilly Announces Plans to Open its First-ever Gateway Labs Site in San Diego
Gateway Labs is Lilly's shared innovation accelerator that provides participating companies with state-of-the-art lab space and unique access to Lilly scientists, researchers and executives, as well as exposure to Lilly's functional and scientific expertise.
Global Pharma | 29/11/2023 | By Manvi | 1056
Akeso Launches Construction of Shanghai Global R&D Center
The groundbreaking ceremony for Akeso Shanghai Global R&D Center was successfully held at the Zhangjiang headquarters park in Shanghai.
Global Pharma | 29/11/2023 | By Manvi | 627
Cipla EU Acquires Additional Stake in JV with Cooper Pharma
Cipla EU acquired an additional 15.1 percent of Cipla Maroc SA, Morocco shares from the The Pharmaceutical Institute (PHI) for MAD 81.1 million or around USD 8.05 million.
Global Pharma | 29/11/2023 | By Manvi | 506
Cadila Pharmaceuticals Inaugurates its State-of-the-Art API Plant at Dahej
Cadila Pharmaceuticals inaugurated its state-of-the-art Active Pharmaceutical Ingredients (API) Plant at Dahej in the Bharuch district.
Global Pharma | 29/11/2023 | By Manvi | 1603
Rusan Pharma Unveils Its State-of-the-Art Facility for APIs in Madhya Pradesh
Rusan Pharma recently achieved a momentous milestone with the launch of its state-of-the-art API facility in Pithampur, Special Economic Zone (SEZ), Madhya Pradesh.
Global Pharma | 29/11/2023 | By Manvi | 1492
It explores the sector’s growth potential on the back of three pivotal imperatives –transformative innovation, fortification of manufacturing and quality standards, and pursuit of sustainable and equitable healthcare.
Global Pharma | 27/11/2023 | By Manvi | 770
DoKaSch Expands Global Presence with New Depot in Dubai
The strategic move strengthens the company's presence in the Middle East and enhances its global network, says an official release.
Global Pharma | 27/11/2023 | By Manvi | 1163
Lupin Receives Approval from US FDA for Bromfenac Ophthalmic Solution, 0.07%
Lupin is the exclusive first-to-file for this product and is eligible for 180-day exclusivity. The product will be manufactured at Lupin’s Pithampur facility in India.
Global Pharma | 27/11/2023 | By Manvi | 701
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy